Kamada (KMDA) to Collaborate with MGH on Study Evaluating Benefit of Liquid Alpha-1 Antitrypsin on Liver Preservation Prior to Transplantation
Tweet Send to a Friend
Kamada Ltd. (NASDAQ: KMDA) announced today a collaboration with Massachusetts General Hospital (MGH) to conduct a proof of concept study ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
